Clinical Trial Management System Market worth 1,065.6 Million USD by 2022 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Clinical Trial Management System Market worth 1,065.6 Million USD by 2022

Description:

The global clinical trial management system market is expected to reach USD 1,065.6 Million by 2022 from USD 534.1 Million in 2016, at a CAGR of 12.6%. – PowerPoint PPT presentation

Number of Views:8

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Clinical Trial Management System Market worth 1,065.6 Million USD by 2022


1
MarketsandMarkets Presents
Clinical Trial Management System Market worth
1,065.6 Million USD by 2022
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
2
The report The report "Clinical Trial Management
System Market by End User (Pharma
Biopharmaceutical Co., Medical Device Co., CROs),
Delivery Mode (Web Hosted, On-premise,
Cloud-based), Type (Enterprise, Site), Component
(Software, Services) - Global Forecast to 2022",
The global CTMS market is expected to reach
1,065.6 million by 2022 from USD 590.0 million in
2017, at a CAGR of 12.6. Browse 88 market data
tables 46 figures 266 pages And in-depth TOC on
Clinical Trial Management System
Market Download The PDF Brochure_at_ https//www.ma
rketsandmarkets.com/pdfdownload.asp?id470 The
major factors driving the growth of the CTMS
market include the significant partnerships
between Asian CROs and pharma companies, rising
number of clinical trials in both developing and
developed nations, availability of advanced and
upgraded CTMS solutions, and rising government
support for clinical trials in Asian countries.
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
3
The objectives of this study are as follows.
To define, describe, segment, and forecast the
global clinical trial management systems market
by type, delivery mode, component, end user, and
region. To provide detailed information
regarding the major factors influencing the
growth of the global CTMS market (drivers,
restraints, opportunities, and challenges) To
strategically analyze the micromarkets1 with
respect to individual growth trends, prospects,
and contributions to the total market To
analyze the growth opportunities in the market
for stakeholders and provide details of the
competitive landscape for market leaders To
forecast the market value of market segments with
respect to the four key regions, namely, North
America (US, and Canada), Europe (Germany, UK,
France and RoE), Asia Pacific (China, Japan,
India and RoAPAC), and the Rest of the World.
To profile the key players in the global CTMS
market and comprehensively analyze their market
rank and core competencies
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
4
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
5
The enterprise CTMS segment is estimated to
account for the largest share of the CTMS market
by type in 2017 The CTMS market is segmented
into enterprise CTMS and site CTMS on the basis
of type. The enterprise CTMS segment is expected
to command the largest share of the global CTMS
market in 2017, and is expected to grow at the
highest CAGR in the forecast period. Talk to Our
Research Experts_at_ https//www.marketsandmarkets.c
om/speaktoanalyst.asp?id470 This is attributed
to the widespread adoption of enterprise CTMS by
majority of the end users.
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
6
The pharmaceutical and biopharmaceutical
companies segment is expected to hold the largest
share of the market in 2017 By end user, the
CTMS market is segmented into pharmaceutical and
biopharmaceutical companies, contract research
organizations, medical device companies, and
others. The pharmaceutical and biopharmaceutical
companies segment is further subsegmented into
large pharmaceutical companies and mid-small
pharmaceutical companies. The pharmaceutical
and biopharmaceutical companies segment is
expected to account for the largest share of the
CTMS market in 2017. The largest share is
attributed to the increasing adoption of CTMS
software during drug clinical trials by
pharmaceutical and biopharmaceutical companies.
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
7
North America is expected to dominate the CTMS
market during the forecast period Geographically,
the CTMS market is segmented into North America,
Europe, Asia Pacific, and the rest of the world.
North America is expected to account for the
largest share of the global CTMS market during
the forecast period (2017-2022). Factors such
as rising number of on-going clinical trials
(especially in the US), presence of leading
players from both demand and supply sides, and
government funding for clinical research are
contributing to the large share of the North
American region. The major players operating in
the CTMS market include Oracle (US), Medidata
Solutions (US), PAREXEL (US), Bioclinica (US),
Bio-Optronics (US), and IBM (US).
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
8
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
https//www.marketsandmarkets.com/Market-Reports/c
linical-trial-management-systems-market-470.html
9
Contact Us
Mr. Shelly Singh MarketsandMarkets INC. 630
Dundee Road Suite 430 Northbrook, IL 60062 USA
1-888-600-6441 Email sales_at_marketsandmarkets.c
om MarketsandMarkets Bloghttp//www.marketsandma
rkets.comhttp//twitter.com/marketsmarkets http/
/www.linkedin.com/company/marketsandmarkets
10
(No Transcript)
About PowerShow.com